AU1438001A - 27 human secreted proteins - Google Patents
27 human secreted proteinsInfo
- Publication number
- AU1438001A AU1438001A AU14380/01A AU1438001A AU1438001A AU 1438001 A AU1438001 A AU 1438001A AU 14380/01 A AU14380/01 A AU 14380/01A AU 1438001 A AU1438001 A AU 1438001A AU 1438001 A AU1438001 A AU 1438001A
- Authority
- AU
- Australia
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16224099P | 1999-10-29 | 1999-10-29 | |
| US60162240 | 1999-10-29 | ||
| US21513100P | 2000-06-30 | 2000-06-30 | |
| US60215131 | 2000-06-30 | ||
| PCT/US2000/029362 WO2001032910A2 (en) | 1999-10-29 | 2000-10-25 | 27 human secreted proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1438001A true AU1438001A (en) | 2001-05-14 |
Family
ID=26858569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU14380/01A Abandoned AU1438001A (en) | 1999-10-29 | 2000-10-25 | 27 human secreted proteins |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1224285A4 (en) |
| JP (1) | JP2003528587A (en) |
| AU (1) | AU1438001A (en) |
| CA (1) | CA2388822A1 (en) |
| WO (1) | WO2001032910A2 (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060172296A1 (en) * | 2002-07-22 | 2006-08-03 | Masahiro Takeuchi | Novel gene associated with rheumatoid arthritis |
| DK2322221T3 (en) | 2008-08-05 | 2014-09-01 | Toray Industries | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF CANCER |
| DK2733492T3 (en) * | 2008-08-05 | 2016-04-25 | Toray Industries | Method for detection of cancer |
| KR101843807B1 (en) | 2010-02-04 | 2018-03-30 | 도레이 카부시키가이샤 | Pharmaceutical agent for treatment and/or prevention of cancer |
| WO2011096519A1 (en) | 2010-02-04 | 2011-08-11 | 東レ株式会社 | Medicinal composition for treating and/or preventing cancer |
| CN102821788B (en) | 2010-02-04 | 2016-11-16 | 东丽株式会社 | The treatment of cancer and/or prophylactic compositions |
| CA2788545C (en) | 2010-02-04 | 2019-03-26 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| RU2603742C2 (en) | 2010-02-04 | 2016-11-27 | Торэй Индастриз, Инк. | Pharmaceutical composition for treatment and/or prevention of cancer |
| PT2532366T (en) | 2010-02-04 | 2016-12-20 | Toray Industries | Pharmaceutical composition for treating and/or preventing cancer |
| CA2844030C (en) | 2011-08-04 | 2019-09-03 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| RU2624049C2 (en) | 2011-08-04 | 2017-06-30 | Торэй Индастриз, Инк. | Pharmaceutical composition for cancer treatment and prevention |
| US9273128B2 (en) | 2011-08-04 | 2016-03-01 | Toray Industries, Inc | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| CN103718045B (en) | 2011-08-04 | 2016-08-17 | 东丽株式会社 | The detection method of pancreas cancer |
| MX348577B (en) | 2011-08-04 | 2017-06-20 | Toray Industries | Cancer treatment and/or prevention drug composition. |
| ES2609846T3 (en) | 2011-08-04 | 2017-04-24 | Toray Industries, Inc. | Pharmaceutical composition for the treatment and / or prevention of pancreatic cancer |
| AU2012290954B2 (en) | 2011-08-04 | 2017-08-31 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| RU2631804C2 (en) | 2012-02-21 | 2017-09-26 | Торэй Индастриз, Инк. | Pharmaceutical composition for cancer treatment or prevention |
| ES2739612T3 (en) | 2012-02-21 | 2020-02-03 | Toray Industries | Pharmaceutical composition for cancer treatment |
| EP2824114B1 (en) | 2012-02-21 | 2019-05-22 | Toray Industries, Inc. | Pharmaceutical composition for treatment of cancer |
| KR102005308B1 (en) | 2012-02-21 | 2019-07-30 | 도레이 카부시키가이샤 | Pharmaceutical composition for treatment and/or prevention of cancer |
| WO2013147169A1 (en) | 2012-03-30 | 2013-10-03 | 東レ株式会社 | Pharmaceutical composition for treatment and/or prevention of liver cancer |
| US9428581B2 (en) | 2012-03-30 | 2016-08-30 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of gallbladder cancer |
| HUE043162T2 (en) | 2012-07-19 | 2019-08-28 | Toray Industries | Method for detecting cancer |
| US9753038B2 (en) | 2012-07-19 | 2017-09-05 | Toray Industries, Inc. | Method for detecting cancer via measurement of caprin-1 expression level |
| CA2918989C (en) | 2013-08-09 | 2021-11-02 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965138A (en) * | 1985-09-06 | 1999-10-12 | Syntro Corporation | Recombinant chimeric virus and uses thereof |
| US5830649A (en) * | 1995-05-26 | 1998-11-03 | Smithkline Beecham Corporation | Human galactokinase gene |
| AU2001264563A1 (en) * | 2000-04-12 | 2001-10-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
-
2000
- 2000-10-25 AU AU14380/01A patent/AU1438001A/en not_active Abandoned
- 2000-10-25 WO PCT/US2000/029362 patent/WO2001032910A2/en not_active Application Discontinuation
- 2000-10-25 EP EP00976635A patent/EP1224285A4/en not_active Withdrawn
- 2000-10-25 CA CA002388822A patent/CA2388822A1/en not_active Abandoned
- 2000-10-25 JP JP2001535590A patent/JP2003528587A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1224285A2 (en) | 2002-07-24 |
| JP2003528587A (en) | 2003-09-30 |
| EP1224285A4 (en) | 2004-12-08 |
| WO2001032910A3 (en) | 2002-01-24 |
| CA2388822A1 (en) | 2001-05-10 |
| WO2001032910A2 (en) | 2001-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1473501A (en) | 21 human secreted proteins | |
| AU1604401A (en) | 18 human secreted proteins | |
| AU1438001A (en) | 27 human secreted proteins | |
| AU1448701A (en) | 15 human secreted proteins | |
| AU1334101A (en) | 19 human secreted proteins | |
| AU3769700A (en) | 45 human secreted proteins | |
| AU5129600A (en) | 143 human secreted proteins | |
| AU2757500A (en) | 33 human secreted proteins | |
| AU1918601A (en) | 23 human secreted proteins | |
| AU3517000A (en) | 50 human secreted proteins | |
| AU1916101A (en) | 19 human secreted proteins | |
| AU3628600A (en) | 46 human secreted proteins | |
| AU1342501A (en) | 32 human secreted proteins | |
| AU3765500A (en) | 50 human secreted proteins | |
| AU3208700A (en) | 33 human secreted proteins | |
| AU3249300A (en) | 47 human secreted proteins | |
| AU3396600A (en) | 49 human secreted proteins | |
| AU1449001A (en) | 28 human secreted proteins | |
| AU1472801A (en) | 24 human secreted proteins | |
| AU3871300A (en) | 50 human secreted proteins | |
| AU3628700A (en) | 49 human secreted proteins | |
| AU3766800A (en) | 48 human secreted proteins | |
| AU3767300A (en) | 47 human secreted proteins | |
| AU1655701A (en) | 15 human secreted proteins | |
| AU3747000A (en) | 49 human secreted proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |